Update about page

app/about/AboutContent.mdx

@@ -1,56 +1,51 @@
-
-This tool, developed by the FRONTIER Research Group at the
-University of Sydney, is designed to assist clinicians in
-screening patients for dementia.
+This tool, developed by the FRONTIER Research Group at the University of
+Sydney, is designed to assist clinicians in screening patients for
+dementia.
 
 ### Clinician Notice
 
 This tool is intended for use only by clinicians trained in
-administering and interpreting the ACE-III. It is a screening
-tool, not a diagnostic instrument, and provides a risk score to
-guide further diagnostic evaluations. It does not diagnose
-dementia.
+administering and interpreting the ACE-III. It is a screening tool, not
+a diagnostic instrument, and provides a risk score to guide further
+diagnostic evaluations. It does not diagnose dementia.
 
 ### About FRONTIER
 
-The FRONTIER Research Group, based at the Brain and Mind Centre,
-University of Sydney, specialises in the study of younger-onset
-dementias. Patients in the FRONTIER programme are typically
-assessed every 12 months until discontinuation. Assessments
-typically include a comprehensive neurological exam, a
-neuropsychological evaluation, and a structural brain MRI,
-completed within a 3-month period. For more information on
-FRONTIER assessment procedures, visit [https://osf.io/6hpax/](https://osf.io/6hpax/).
+FRONTIER is based at the Brain and Mind Centre, University of Sydney,
+and specialises in the study of younger-onset dementias. Patients in the
+FRONTIER research programme are typically assessed every 12 months until
+discontinuation. Assessments typically include a comprehensive
+neurological examination, a neuropsychological assessment, and a
+structural brain MRI, completed within a 3-month period. For more
+information on FRONTIER assessment procedures, visit [https://osf.io/6hpax/](https://osf.io/6hpax/).
 
 ### About the Dataset
 
-This case-control study included participants recruited from
-September 2011 to December 2023. It comprises 431 patients with
-dementia (409 with a major neurocognitive disorder and 22 with a
-minor neurocognitive disorder at the last clinical assessment) and
-107 non-dementia controls.
-
-The dataset includes annual repeat
-assessments, resulting in 844 ACE-III assessments from patients
-with dementia (789 with a major and 55 with a minor neurocognitive
-disorder) and 224 ACE-III assessments from non-dementia controls.
-This dataset is based on performance profiles from the Australian
-version of the ACE-III. The dementia risk value is derived from a
-binomial logistic regression model. For more information about the
-dataset and model, visit [https://osf.io/6hpax/](https://osf.io/6hpax/).
-
-### Financial support
-
-This tool was developed with support from the Edwards Fund for
-Dementia Research at the Brain and Mind Centre, University of
-Sydney. Contact For questions about the ACE-III Online Dementia
-Screening Tool, please contact FRONTIER at [[email protected]](mailto:[email protected]).
-To learn more about the ACE-III or download the test and
-administration guide, visit [https://frontierftd.org](https://frontierftd.org).
+This case-control study included participants recruited from September
+2011 to December 2023. It comprises 431 patients with dementia (409 with
+a major neurocognitive disorder and 22 with a minor neurocognitive
+disorder at the last clinical assessment) and 107 non-dementia controls.
+
+The dataset includes annual repeat assessments, resulting in 844 ACE-III
+assessments from patients with dementia (789 with a major and 55 with a
+minor neurocognitive disorder) and 224 ACE-III assessments from
+non-dementia controls. This dataset is based on performance profiles
+from the Australian version of the ACE-III. The dementia risk value is
+derived from a binomial logistic regression model. For more information
+about the dataset and model, visit [https://osf.io/6hpax/](https://osf.io/6hpax/).
+
+### Financial Support
+
+This tool was developed with support from the Edwards Fund for Dementia
+Research and the Steven Warman Research Fund in Frontotemporal Dementia
+at the Brain and Mind Centre, University of Sydney. This tool was also
+supported in part by funding from the National Health and Medical
+Research Council (NHMRC) (GNT1037746, GNT2024329, GNT2025228,
+GNT2008020) and the Australian Research Council (ARC) Centre of
+Excellence in Cognition and its Disorders Memory Program (CE11000102).
 
 ### Contact
-For questions about the ACE-III Online Dementia Screening Tool,
-please contact FRONTIER at
-[[email protected]](mailto:[email protected]).
-To learn more about the ACE-III or download the test and
-administration guide, visit [https://frontierftd.org](https://frontierftd.org).
+
+For questions about the ACE-III Online Dementia Screening Tool, please
+contact FRONTIER at [[email protected]]([email protected]). To learn more about the
+ACE-III or download the test and administration guide, visit [https://frontierftd.org](https://frontierftd.org).

app/about/page.tsx

@@ -15,7 +15,10 @@ export default function About() {
   return (
     <main className="container mx-auto min-h-screen md:p-2">
       <div className="flex flex-col justify-start items-center gap-2 md:gap-4">
-        <Card className="min-w-96 max-w-2xl" theme={NoPaddingCardTheme}>
+        <Card
+          className="min-w-96 max-w-2xl mt-0 md:mt-4"
+          theme={NoPaddingCardTheme}
+        >
           <div className="flex items-center justify-between">
             <h2 className="text-lg text-indigo-600 font-semibold">
               Welcome to the Addenbrooke’s Cognitive Examination-III (ACE-III)